Johnson & Johnson Stock

• COVID-19 vaccine maker Johnson & Johnson splitting into two companies

  Johnson & Johnson, a medical manufacturing titan and COVID-19 vaccine maker, has announced it is dividing its business into two companies for better market impact.

  World

  Nov 12, 2021
  
• J&J expects to sell $2.5B in COVID-19 vaccines this year despite safety issues

  J&J expects to produce 500 million to 600 million doses of the vaccine this year, Chief Financial Officer Joseph Wolk said.

  Money

  Jul 21, 2021
  
• Advertisement
• Johnson & Johnson one-shot vaccine is safe, prevents COVID-19, U.S. FDA says

  The agency's independent advisers will debate if the evidence is strong enough to recommend the long-anticipated shot.

  World

  Feb 24, 2021
• Advertisement
• Johnson & Johnson’s one-dose coronavirus shot appears less effective than others

  The company's results compare to the high bar set by two authorized vaccines from Pfizer Inc/BioNTech SE and Moderna Inc, which were around 95% effective.

  World

  Jan 29, 2021